Find uplifting stories about heroes, innovations, and solutions
96 results for "drug development"
A groundbreaking new drug nearly doubled survival time for people with advanced pancreatic cancer, marking the biggest treatment advance in over a decade. The success is sparking hope that other hard-to-treat cancers could soon follow.
A once-basic lab tool is now helping scientists discover life-saving drugs faster than ever before. Mass spectrometry technology is cutting years off the drug development process by spotting failed candidates early and revealing how medicines actually work inside the body.
Scientists are testing multiple Alzheimer's treatments simultaneously in one ongoing trial, slashing the decade-long wait between failed attempts. The approach has already proven it works in motor neuron disease research.
A groundbreaking treatment has achieved functional cures in one-fifth of chronic hepatitis B patients, offering hope for a disease that affects 296 million people worldwide. The weekly injection made the virus undetectable even after treatment stopped.
After decades of failed attempts, Finnish researchers have identified two drug molecules that successfully trigger myelin repair in multiple sclerosis models. Both compounds crossed the blood-brain barrier and worked through entirely different mechanisms to achieve the same remarkable result.
Researchers in Germany invented a light-powered method to create tiny "housane" molecules that could revolutionize drug development. The breakthrough makes it easier to build the same type of strained molecular structures found in medicines like penicillin.
Scientists at MIT developed glowing nanoparticles that track cancer proteins for hours instead of seconds, revealing how they behave in living cells. The breakthrough could transform drug development and help explain why some mutations cause aggressive cancers.
Flinders University researchers have developed a breakthrough drug treatment for sleep apnea that could receive US approval next year. The innovation offers new hope to more than one million Australians living with the dangerous sleep disorder. ---
German researchers have developed a breakthrough drug that outperformed popular weight-loss medications in early tests, targeting five body systems at once. The "quintuple agonist" could mean better results with fewer side effects, though human trials are still needed.
A publicly traded pharmaceutical company just invested its own money to manufacture drugs in space for the first time. This milestone could transform how we make life-saving medications.
The World Health Organization is leading a global push to develop new antifungal treatments as drug-resistant fungal infections claim millions of lives annually. Researchers are working on innovative solutions while calling for smarter use of existing drugs.
Researchers discovered how enteroviruses hijack human cells to multiply, revealing a molecular switch that could lead to drugs treating dozens of viruses at once. The breakthrough offers hope for a universal antiviral against polio, myocarditis, and even the common cold.
Two companies are teaming up to manufacture medicines in orbit, where zero gravity could create more effective treatments for people with rare lung diseases. The first missions launch in 2026, bridging decades of space research with real patient benefits.
A Hong Kong biotech startup is using artificial intelligence to design "nano-rockets" that deliver life-saving drugs, slashing development time from years to just 18 months. METiS TechBio's stock soared 173% on its market debut as investors rushed to back the breakthrough technology.
South Korea just passed groundbreaking legislation to support quantum computing merged with AI, targeting everything from new drug development to national security. The country is positioning itself to lead the next wave of tech innovation beyond traditional AI.
South Korea approved its 42nd and 43rd domestically developed drugs in April alone, marking a dramatic acceleration in medical innovation. After averaging just two approvals per year for two decades, the country is on track for a record-breaking 2026.
A Korean biotech company's AI software that forecasts clinical trial outcomes with 80% accuracy is heading to American labs. Boston-based Cambridge Scientific will distribute the platform to help drug developers save time and money on experiments. #
Ten robots at Tokyo University conduct complex medical experiments around the clock without any human supervision. This fully automated lab could slash drug development time from decades to years.
Scientists are on the brink of two major breakthroughs that could revolutionize drug development and disease treatment. New AI systems can now predict how proteins change shape and design custom proteins that bind to disease targets with stunning accuracy.
Families with rare disease children are attending free bootcamps that teach them how to develop their own treatments. Half of the groups trained in 2019 reached clinical trials within five years.
Showing 20 of 96